What’s next for rare myelomas?
Is FISH becoming obsolete in multiple myeloma?
The differences in treating older versus younger CLL patients
The influence of the European Research Initiative on CLL (ERIC)
How to avoid tumor lysis syndrome when treating CLL patients with venetoclax